News for Quest Diagnostics Incorporated (0KSX.L)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

This is the go-to destination for dividend growth investing conversations on Seeking Alpha.

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ETCompany ParticipantsJim Davis - President & CEOSam...

U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Thursday. Shares of International Business Machines Corporation IBM gained 12.8%...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireSECAUCUS, N.J., Jan. 2, 2025 SECAUCUS, N.J., Jan. 2, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic inf

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

PR NewswireSECAUCUS, N.J., Dec. 3, 2024 SECAUCUS, N.J., Dec. 3, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic inf

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts.

A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.

Labcorp Holdings Inc. (LH) has announced a significant change in its executive leadership team. On November 15, 2024, Glenn Eisenberg, the company's Executive

Quest Diagnostics stock hits 52-week high of $162.68

The U.S. Point of Care Diagnostics Market Size sector reached a market value of USD 9.45 billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 6.9%…

The COVID-19 Diagnostics Market Size sector reached a market value of USD 46.76 Billion in 2021. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of -13.1% from…

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

The cholesterol test market is experiencing robust growth, driven by increasing consumer demand for preventive healthcare solutions and advancements in...

The increasing demand for clinical laboratory services is mainly driven by the rising prevalence of chronic and infectious diseases, lifestyle-related...

As per Fortune Business Insights’ report, the Esoteric Testing Market share sector attained a worth of USD 22.21 billion in 2022. Forecasts indicate a promising path, foreseeing a Compound Annual…